References:
1. Al-Mamgani A, van Rooij P, Verduijn GM, Meeuwis CA, Levendag PC.
Long-term outcomes and quality of life of 186 patients with primary
parotid carcinoma treated with surgery and radiotherapy at the Daniel
den Hoed Cancer Center. International Journal of Radiation Oncology*
Biology* Physics. 2012;84(1):189-95.
2. Ord RA, Ghazali N. Margin analysis: malignant salivary gland
neoplasms of the head and neck. Oral and Maxillofacial Surgery Clinics.
2017;29(3):315-24.
3. Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a
defined UK population. British Journal of Oral and Maxillofacial
Surgery. 2013;51(5):399-403.
4. Slootweg PJ, El-Naggar AK. World Health Organization 4th edition of
head and neck tumor classification: insight into the consequential
modifications. Virchows Archiv. 2018;472(3):311-3.
5. Lin HH, Limesand KH, Ann DK. Current State of Knowledge on Salivary
Gland Cancers. Critical Reviews™ in Oncogenesis. 2018;23(3-4).
6. Gutschenritter T, Machiorlatti M, Vesely S, Ahmad B, Razaq W, Razaq
M. Outcomes and Prognostic Factors of Resected Salivary Gland
Malignancies: Examining a Single Institution’s 12-year Experience.
Anticancer research. 2017;37(9):5019-25.
7. Kandaz M, Soydemir G, Bahat Z, Canyilmaz E, Yoney A. Prognostic
factors and clinical outcome in parotid gland tumors: a single
institution experience from the eastern black sea region of Turkey.
Asian Pacific Journal of Cancer Prevention. 2016;17(3):1169-74.
8. Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD, Faratzis G,
Lagogiannis GA, et al. Mucoepidermoid carcinoma of the salivary glands.:
Review of the literature and clinicopathological analysis of 18
patients. Oral oncology. 2007;43(2):130-6.
9. Ferrell JK, Mace JC, Clayburgh D. Contemporary treatment patterns and
outcomes of salivary gland carcinoma: a National Cancer Database review.
European Archives of Oto-Rhino-Laryngology. 2019;276(4):1135-46.
10. de Ridder M, Balm AJ, Smeele LE, Wouters MW, van Dijk BA. An
epidemiological evaluation of salivary gland cancer in the Netherlands
(1989–2010). Cancer epidemiology. 2015;39(1):14-20.
11. England PH. Epidemiology and management of major salivary gland
cancers2016. Available from:
https://kclpure.kcl.ac.uk/portal/files/77534661/Epidemiology_and_management_GIRDLER_PublishedSeptember2016_GOLD_VoR.pdf.
12. Liu Y, Qin L, Zhuang R, Huang X, Su M, Han Z. Nodal Stage: Is It a
Prognostic Factor for Submandibular Gland Cancer? Journal of Oral and
Maxillofacial Surgery. 2018;76(8):1794-9.
13. Israel Y, Rachmiel A, Gourevich K, Nagler R. Kaplan–Meier analysis
of salivary gland tumors: prognosis and long-term survival. Journal of
cancer research and clinical oncology. 2019;145(8):2123-30.
14. Amit M, Eran A, Billan S, Fridman E, Na’ara S, Charas T, et al.
Perineural spread in noncutaneous head and neck cancer: new insights
into an old problem. Journal of Neurological Surgery Part B: Skull Base.
2016;77(02):086-95.
15. Terhaard CH, Lubsen H, Van der Tweel I, Hilgers F, Eijkenboom W,
Marres H, et al. Salivary gland carcinoma: independent prognostic
factors for locoregional control, distant metastases, and overall
survival: results of the Dutch head and neck oncology cooperative group.
Head & Neck: Journal for the Sciences and Specialties of the Head and
Neck. 2004;26(8):681-93.
16. Son E, Panwar A, Mosher CH, Lydiatt D. Cancers of the major salivary
gland. Journal of oncology practice. 2018;14(2):99-108.
17. Guntinas-Lichius O, Silver CE, Thielker J, Bernal-Sprekelsen M,
Bradford CR, De Bree R, et al. Management of the facial nerve in parotid
cancer: preservation or resection and reconstruction. Eur Arch
Otorhinolaryngol. 2018;275(11):2615-26.
18. Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, et al.
Adjuvant therapy in major salivary gland cancers: analysis of 8580
patients in the National Cancer Database. Head & neck.
2018;40(7):1343-55.